Transition Binder for New Chairperson, Thomas Digby, 2023

Information supplied to the Chairperson of the Patented Medicine Prices Review Board, Thomas J. Digby as of February 1, 2023.

Données et ressources

Info additionnelle

Champ Valeur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward